Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755286 · ClinicalTrials.gov registry record · Phase 1
OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement
A Phase 1 study of Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement, sponsored by Otonomy.
- Completed
- Registry status
- Phase 1
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT01755286 is a Phase 1 study of Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement that has completed, run by Otonomy. The registered enrollment target is 83 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01755286, a Phase 1 study of Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement, has completed, sponsored by Otonomy.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe the safety and tolerability of two dose levels of OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Sham
- DRUG OTO-201
Study Locations (1)
California
- Call/Email Otonomy Central Contact for Trial Locations - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755286
The ClinicalTrials.gov registry entry for NCT01755286 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otonomy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT01755286 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01755286 about?
NCT01755286 is a clinical study titled "OTO-201 for Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement". The purpose of this study is to describe the safety and tolerability of two dose levels of OTO-201, placebo and sham when administered intra-operatively in pediatric subjects with bilateral middle ear effusion who require tympanostomy tube placement.
What is the current status of trial NCT01755286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 83 participants. The study started on 2012-12. Estimated completion is 2013-06.
What conditions does trial NCT01755286 study?
This clinical trial studies the following conditions: Bilateral Middle Ear Effusion Requiring Tympanostomy Tube Placement.
What interventions are being tested in trial NCT01755286?
The interventions under investigation include: Placebo (DRUG), Sham (DRUG), OTO-201 (DRUG).
Who is sponsoring clinical trial NCT01755286?
This trial is sponsored by Otonomy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01755286 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.